Genetics
FORMULATRIX® Digital PCR Technology to Be Acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. for up to $260 million ($125 million upfront payment and $135 million of milestones). QIAGEN has announced plans for a global launch…